Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWynnstay Regulatory News (WYN)

Share Price Information for Wynnstay (WYN)

Share Price is delayed by 15 minutes
Get Live Data
345.00    0.00 (0.00%)
Bid:
340.00
Ask:
350.00
Spread: 10.00 (2.941%)
Market Cap: £79.42m
WYN Live PriceLast checked at - London Stock Exchange

Intraday Wynnstay Share Chart

AGM Statement

22 Mar 2022 07:00

RNS Number : 5023F
Wynnstay Group PLC
22 March 2022
Β 

22 March 2022

AIM: WYN

Β 

Β 

Wynnstay Group plc

("Wynnstay" or "the Group")

Β 

AGM Statement

Β 

Wynnstay, the agricultural and specialist merchanting group, will be holding its Annual General Meeting this morning and Chairman, Steve Ellwood, will make the following comment on current trading:

"I am pleased to report that trading in the first four months of the new financial year has been in line with management expectations across core activities, while fertiliser operations at Glasson have continued to experience one-off gains from the exceptional current trading environment that has been sustained into the current financial year. Market volatility across most commodities has persisted, with material price increases since the start of the calendar year. The recent outbreak of war in Ukraine has exacerbated this, and raised concerns over the supply of fertiliser and wheat, in particular. Energy and transport costs also remain a challenge. Wynnstay has managed these difficult circumstances well, and once again the Group's broad spread of activities is proving a major strength. Farmgate prices have remained strong, enabling customers to absorb elements of this inflation, although higher prices are expected to curtail some demand.

"On 18 March, the business completed the acquisition of Humphrey Feeds Ltd and its associated pullets business for an initial consideration of Β£9.5m. As previously reported, the acquisition is expected to be immediately earnings enhancing, and furthers the Group's feed activity in the growing free range egg sector, expands its manufacturing capacity, and opens up expansion opportunities in the South of England.

"The Board remains very grateful for the resilience and support demonstrated by all colleagues, especially as the coronavirus pandemic has more recently caused increased levels of absence through necessary self-isolation. Investment plans continue and will support growth and greater efficiencies. Wynnstay remains well-placed to achieve its goals for the current financial year."

Β 

Enquiries:

Wynnstay Group plc

Gareth Davies, Chief Executive

Paul Roberts, Finance Director

T: 020 3178 6378 (today)

T: 01691 827 142

Β 

Β 

Β 

KTZ Communications

Katie Tzouliadis

Dan Mahoney

T: 020 3178 6378

Β 

Β 

Β 

Shore Capital (Nomad and Broker)

Stephane Auton / Patrick Castle

John More

T: 020 7408 4090

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
AGMUAONRUOUOUAR
Date   Source Headline
5th May 20262:31 pmRNSDirector and PDMR Shareholding
1st May 20267:00 amRNSAward of Options and Total Voting Rights
26th Mar 20263:31 pmRNSDirector/PDMR Shareholding
24th Mar 20265:11 pmRNSResult of AGM
24th Mar 20267:00 amRNSAGM Statement
2nd Mar 20267:00 amRNSBlock Listing Return
13th Feb 20263:30 pmRNSDirector/PDMR Shareholding
9th Feb 20264:40 pmRNSDividend timetable
9th Feb 20267:00 amRNSFinal Results
26th Jan 20267:00 amRNSNotice of Results and Investor presentation
29th Dec 202510:05 amRNSHolding(s) in Company
29th Dec 202510:05 amRNSHolding(s) in Company
1st Dec 202511:44 amRNSDirector/PDMR Share Purchases
1st Dec 20257:00 amRNSTrading Update
3rd Nov 20256:25 pmRNSDirector/PDMR Shareholding
6th Oct 20251:51 pmRNSDirector and PDMR dealing
24th Sep 20256:01 pmRNSDirector and PDMR dealing - Replacement
24th Sep 20253:50 pmRNSDirector and PDMR dealing
24th Sep 202512:05 pmRNSDirector and PDMR dealing
1st Sep 20257:00 amRNSBlock Listing Return
5th Aug 20255:10 pmRNSDirector Share Purchases
2nd Jul 20253:44 pmRNSPCA dealing
1st Jul 20252:20 pmRNSDirector Share Purchase
1st Jul 20257:00 amRNSInterim Results
16th Jun 20257:00 amRNSNotice of Results
2nd May 20257:00 amRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSDirector and PDMR dealing
30th Apr 202511:55 amRNSDirector/PDMR Shareholding
29th Apr 20254:22 pmRNSDirector and PDMR dealing
25th Apr 20253:04 pmRNSDirector/PDMR Shareholding
1st Apr 20259:26 amRNSDirector/PDMR Shareholding
27th Mar 20253:36 pmRNSResult of AGM
27th Mar 20257:00 amRNSAGM Update
25th Mar 20257:00 amRNSBoard Appointments
3rd Mar 202511:28 amRNSBlock Listing Return
27th Feb 20251:57 pmRNSChanges to Employee Share Scheme and TVR
20th Feb 20252:46 pmRNSDirector Dealing and Total Voting Rights
18th Feb 20254:32 pmRNSExercise of Options and Total Voting Rights
13th Feb 20255:31 pmRNSExercise of Options and Total Voting Rights
13th Feb 202512:54 pmRNSHolding(s) in Company - TR-1 Notification
12th Feb 20255:39 pmRNSExercise of Options, Director Dealings and TVR
11th Feb 20256:42 pmRNSDirector/PDMR dealings, Award of Options, TVR
11th Feb 20255:59 pmRNSCorrection of record date for final dividend
11th Feb 20257:00 amRNSFinal Results
21st Jan 20257:00 amRNSNotice of Final Results
31st Oct 20247:00 amRNSScrip dividend election, PDMR Dealing, TVR
30th Oct 20244:47 pmRNSDirector/PDMR Shareholdings
23rd Oct 20244:35 pmRNSDirector/PDMR Shareholding
18th Oct 20244:28 pmRNSTR-1 Notification
14th Oct 20244:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.